Anaphylaxis News and Research

RSS

Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.

Hay fever could be triggering other allergies, doctor reveals

Hay fever may be triggering an allergic reaction to foods such as fruits, vegetables, nuts and legumes, a doctor from a digital healthcare provider has revealed.

8 May 2023

Study assesses trends in buprenorphine initiation and retention in the United States

Treating opioid addiction should be much easier now than it was a few years ago, thanks to pandemic-era rule changes that aim to improve access to buprenorphine, a medicine proven to help in recovery.

25 Apr 2023

Diagnosis and treatment of food allergies using a molecular approach

Researchers discuss molecular methods for food allergy assessments, including diagnostic and prognostic markers, as well as existing therapies.

15 Mar 2023

A call to action proposed for health providers to ensure widest distribution, easy availability of naloxone

In 2021, 100,306 Americans died from drug overdoses – a 28.5 percent increase from the prior year – with 75,673 attributed to opioids.

16 Feb 2023

Researchers find a way to block anaphylaxis caused by peanut allergies

Researchers from Indiana University School of Medicine have found a way to block anaphylaxis caused by peanut allergies.

9 Feb 2023

Researcher contextualizes a study on IgG4 anti-Spike levels after repeated SARS-CoV-2 mRNA vaccination

A researchers emphasized the need to reconsider mRNA COVID-19 vaccination strategies in the future,

9 Feb 2023

Mount Sinai scientists earn $12 million to elucidate novel causes of food allergies and atopic dermatitis

Mount Sinai researchers have been awarded $12 million over five years by the National Institutes of Health to create a center to elucidate novel causes of, and contributing factors to, food allergies and atopic dermatitis.

25 Jan 2023

High burden of multi-food allergies among children and adults in the U.S.

A new study in the journal Annals of Allergy, Asthma & Immunology aimed to characterize the characteristics, prevalence, determinants, distribution, and psychosocial burden of multi-FA among adults and children in the US.

3 Jan 2023

New technologies and recent advances in the study of T cells and T-cell epitope discovery in food allergy research

In a recent study, scientists reviewed the latest technological advancements and T cell epitope discovery associated with food allergy.

28 Nov 2022

Study sheds new light on the role of IgA in food allergies

Food-specific immunoglobulin A present in the human gut does not provide protection against food allergies.

27 Nov 2022

Study: Only half of food allergic adult patients have immediate access to epinephrine

Epinephrine is the only medication that can stop anaphylaxis and it is critical that everyone with a food allergy has access to epinephrine to treat life threatening reactions.

10 Nov 2022

Treatment using CRISPR genome editing alleviates swelling attacks in hereditary angioedema patients

Hereditary angioedema (HAE) is a rare, genetic disorder characterized by severe, recurring, and unpredictable swelling attacks in various organs and tissues of the body, which can be painful, debilitating, and life-threatening.

10 Nov 2022

Anaphylaxis symptoms in most infants appear to resolve with a single dose of epinephrine

Although many parents of infants worry about their child having a food allergy, there has not been a lot of research into the presentation of anaphylaxis in infants.

10 Nov 2022

CDC Director signs decision memo allowing Novavax monovalent COVID-19 boosters for adults

Today, CDC's Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.

24 Oct 2022

Comparative immunogenicity of COVID-19 vaccines in North California

In new research, researchers evaluated vaccine responses among North Californian residents, including differences in vaccine side effects and antibody (Ab) titers by age, sex, and vaccine type.

4 Oct 2022

Novel peanut-specific human IgE monoclonal antibodies may uncover new therapeutic targets for peanut allergy

A recent Frontiers in Immunology journal study by University of North Carolina at Chapel Hill and Vanderbilt University researchers has created an in vitro system to determine potential therapeutics targeting sensitized effector cells based on human, allergen-specific, Immunoglobulin E (IgE) monoclonal antibodies (mAbs).

2 Oct 2022

Trial tests efficacy and safety of NVX-CoV2373 COVID-19 vaccine among adolescents

In a recent study posted to the medRxiv* preprint server, researchers in the United States described the safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), tested in PREVENT-19 — a phase 3, randomized, placebo-controlled, observer-blinded trial among 12- to 17-year-old adolescents in the United States (U.S).

25 Sep 2022

The incidence rates of adverse events of special interest in COVID-19 vaccinated and non-vaccinated persons

Researchers monitored the safety of the four diverse SARS-CoV-2 vaccines approved by the EMA and MHRA in 2020 to 2021.

24 Aug 2022

Updated guidelines on the Valneva SARS-CoV-2 vaccine

The WHO provides interim guidelines for the use of the Valneva vaccine.

23 Aug 2022

Safety and efficacy of tixagevimab–cilgavimab in preventing severe COVID

In a recent study published in the Lancet, researchers evaluated the safety and efficacy of tixagevimab–cilgavimab, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal antibody (mAb) combination in patients with mild to moderate coronavirus disease 2019 (COVID-19).

8 Jun 2022

Anaphylaxis News and Research

Further Reading

Hay fever could be triggering other allergies, doctor reveals

Study assesses trends in buprenorphine initiation and retention in the United States

Diagnosis and treatment of food allergies using a molecular approach

A call to action proposed for health providers to ensure widest distribution, easy availability of naloxone

Researchers find a way to block anaphylaxis caused by peanut allergies

Researcher contextualizes a study on IgG4 anti-Spike levels after repeated SARS-CoV-2 mRNA vaccination

Mount Sinai scientists earn $12 million to elucidate novel causes of food allergies and atopic dermatitis

High burden of multi-food allergies among children and adults in the U.S.

New technologies and recent advances in the study of T cells and T-cell epitope discovery in food allergy research

Study sheds new light on the role of IgA in food allergies

Study: Only half of food allergic adult patients have immediate access to epinephrine

Treatment using CRISPR genome editing alleviates swelling attacks in hereditary angioedema patients

Anaphylaxis symptoms in most infants appear to resolve with a single dose of epinephrine

CDC Director signs decision memo allowing Novavax monovalent COVID-19 boosters for adults

Comparative immunogenicity of COVID-19 vaccines in North California

Novel peanut-specific human IgE monoclonal antibodies may uncover new therapeutic targets for peanut allergy

Trial tests efficacy and safety of NVX-CoV2373 COVID-19 vaccine among adolescents

The incidence rates of adverse events of special interest in COVID-19 vaccinated and non-vaccinated persons

Updated guidelines on the Valneva SARS-CoV-2 vaccine

Safety and efficacy of tixagevimab–cilgavimab in preventing severe COVID

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

Latest News